Lonicera hypoglauca
Lonicera hypoglauca · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Lonicera hypoglauca is a botanical species that has garnered significant scientific interest due to its unique chemical profile. Research focuses heavily on the leaf portions of the plant to isolate its bioactive components. Specifically, the leaf extracts are rich in various polyphenols that demonstrate notable biological activity. Studies have investigated how these preparations interact with specific inflammatory conditions, such as those involving IL-6. Consequently, understanding the relationship between these extracts and cellular responses remains a key area of study.
- Synonyms
- Lonicera Hypoglauca F. Pulchra · Lonicera Buergeriana · 6 more
- Common names
- Not available
- Family
- Caprifoliaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Lonicera hypoglauca is a versatile plant recognized by a diverse array of regional and linguistic names. In various Chinese-speaking contexts, it is frequently referred to as gu xian ren dong, hong xian ren dong, or da jin yin hua. Moving into Japanese nomenclature, the species is known as kidachi-nindō and written in katakana as キダチニンドウ. These varied designations reflect the plant's significant cultural and botanical presence across different territories. Understanding these common names is essential for anyone studying the widespread identity of this specific species.
Sources: Catalogue of Life (COL)
Synonyms
Lonicera hypoglauca is a taxonomically complex species that is identified by several different scientific synonyms. Within botanical literature, it is frequently referred to as Caprifolium hypoglaucum or Caprifolium mollissimum. The plant is also closely linked to various classifications, including Lonicera affinis var. hypoglauca and Lonicera affinis var. pubescens. Furthermore, researchers may encounter this species under the name Lonicera buergeriana in certain contexts. Understanding these overlapping names is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Lonicera hypoglauca is a distinct member of the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It belongs to the specific order Dipsacales, showcasing its unique evolutionary lineage. Further narrowing its identity, it is categorized under the genus Lonicera. Ultimately, this species is a proud representative of the Caprifoliaceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Dipsacales |
| Family | Caprifoliaceae |
| Genus | Lonicera |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Lonicera hypoglauca exhibits a diverse distribution across several distinct regions of Asia. This species is commonly found throughout the temperate zones of China, specifically within the South-Central and Southeast provinces. Its presence extends further into Eastern Asia, where it can be identified in the natural landscapes of both Japan and Taiwan. Additionally, the plant reaches into more tropical climates, making appearances within the Indo-China region of Vietnam. This broad geographic range highlights the adaptability of the species across varying Asian environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Lonicera hypoglauca is characterized by its distinct growth form as a tree.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Lonicera hypoglauca has emerged as a significant subject of study due to its complex chemical composition and potential therapeutic properties. Through advanced UHPLC-HRMS metabolite profiling, researchers have successfully identified several key constituents within its leaves. Notably, the study revealed that Lonicera hypoglauca contains specific bioflavonoids that were isolated for the first time. These compounds, alongside various other metabolites, are being investigated for their potential to act as anti-inflammatory agents. This discovery underscores the importance of utilizing sophisticated analytical methods to uncover the bioactive potential of Chinese Lonicera species.
Conditions
Lonicera hypoglauca effectively treats DSS-induced colitis symptoms by mitigating the physiological impact of the disease in mouse models. This plant extract treats IL-6 by significantly decreasing the levels of this pro-inflammatory cytokine in both serum and colon tissue. It also treats the damaged intestinal barrier by enhancing the expression of key proteins like occludin and zonula occludens-1. Furthermore, Lonicera hypoglauca treats the increased disease activity index (DAI) and helps restore normal colon length. Finally, the plant treats inflammation-related assays by providing bioactive constituents that demonstrate significant anti-inflammatory activity.
Preparations
Lonicera hypoglauca is prepared as extracts, specifically through the use of Lonicera species ethanolic extracts for metabolite profiling. These extracts, referred to as LSEs, are used in studies to mitigate colonic inflammation by regulating oxidative stress and gut microbiota. Furthermore, Lonicera hypoglauca is prepared as leaves to facilitate the isolation of specific bioflavonoids and polyhydroxy fatty acids. The study of these leaf-derived components helps in identifying potentially anti-inflammatory active constituents. Together, these preparation methods allow researchers to explore the therapeutic potential of the plant's bioactive compounds.
Parts used
Lonicera hypoglauca serves as a significant subject in recent pharmacological studies focusing on anti-inflammatory potential. Researchers utilized UHPLC-HRMS-based metabolite profiling to analyze various constituents within this specific species. During this investigation, several unique compounds, including bioflavonoids and acetylated polyhydroxy fatty acids, were successfully isolated from the leaves. These leaf extracts provided the foundation for identifying candidate molecules that could potentially mitigate cellular inflammation. Ultimately, the study highlights the importance of Lonicera hypoglauca as a valuable botanical source for developing new bioactive treatments.